Harvest One Cannabis Inc. (TSX-V:HVT, OTCQB:HRVOF) said it has launched its new LivRelief Infused product stock-keeping unit (SKU), Extra Strength Transdermal CBD Cream.
This new SKU will be available at the Ontario Cannabis Store as part of Harvest One’s brand expansion within the topicals market distribution channels, the company said.
"Harvest One's LivRelief Infused Transdermal CBD Cream continues its momentum as the top-selling SKU in the infused topicals category in Ontario for the 12-month period ended January 2022, as ranked by dollars sold, based on OCS Sales Data,” said Gord Davey, CEO of Harvest One.
He added: “The company is excited to announce the expanded distribution of LivRelief Infused Extra Strength Transdermal CBD Cream, which has been approved for listing at the OCS and will launch this spring at stores across the province.”
READ: Harvest One Cannabis sees sequential revenue grow by 12% in its fiscal 1Q thanks to strong Dream Water and LivRelief sales
Davey noted that Ontario is the province with the largest cannabis consumption in Canada, having over 1,400 retail stores and serving a population of over 14.8M people. “This is another key milestone for Harvest One as we continue to grow and add to our portfolio of infused licensed products."
Pipeline development, product innovation and the expansion of distribution channels are key strategic initiatives for Harvest One and its brands LivRelief and Dream Water.
The company said that it remains committed to innovation and robust product development to ensure it continually meets the needs of the cannabis consumer base.
Additionally, the company said that it intends to further develop its licensed cannabis-infused topicals to bolster its leadership position in the market by expanding its offerings in Canada and other jurisdictions in key global markets as cannabis consumption becomes legal.
Contact Ritika at ritika@proactiveinvestors.com